drugset / Trial / NCT07308938
Fluorometholone Study
Phase 2
Not yet recruiting
174 enrolled
Vishal Jhanji
University of Pittsburgh Medical Center · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The investigators seek to determine whether adjunctive topical fluorometholone (FML) improves best-corrected visual acuity (BCVA) at 3 months in patients with bacterial corneal ulcers compared with standard topical antibiotic therapy alone.
Timeline
- Start
- 2026-10-31
- Primary completion
- 2029-12-31
- Completion
- 2030-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluorometholone | Other / unclassified | 0.1 % | Topical |
| Background | Cefazolin | Small molecule | — | Topical |
| Background | Moxifloxacin | Small molecule | — | Topical |
| Background | Tobramycin | Small molecule | — | Topical |